Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
Public ClinicalTrials.gov record NCT00696241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of azilsartan medoxomil, once daily (QD), compared to placebo and olmesartan in participants with essential hypertension.
Study identification
- NCT ID
- NCT00696241
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,275 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2007 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Jul 29, 2011
2007 – 2008
United States locations
- U.S. sites
- 80
- U.S. states
- 30
- U.S. cities
- 80
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Tempe | Arkansas | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Gatos | California | — | — |
| Not listed | Orangevale | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Farmington | Connecticut | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Naples | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Lawrenceville | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Melrose Park | Illinois | — | — |
| Not listed | Naperville | Illinois | — | — |
| Not listed | Round Lake Beach | Illinois | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Erlanger | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | West Yarmouth | Massachusetts | — | — |
| Not listed | Benzonia | Michigan | — | — |
| Not listed | Chelsea | Michigan | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Trenton | New Jersey | — | — |
| Not listed | Wildwood Crest | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Orangevale | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Salisbury | North Carolina | — | — |
| Not listed | Statesville | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Reading | Pennsylvania | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Taylors | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | New Tazewell | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lake Jackson | Texas | — | — |
| Not listed | North Richland Hills | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Draper | Utah | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Tacoma | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2011 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00696241 live on ClinicalTrials.gov.